Scientific article
English

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Published in

Alzheimer's Research and Therapy, vol. 10, no. 1, 64

Publication date

2018

Abstract

There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. In this report we describe the design of the study, the methods used and the characteristics of the participants.

Citation (ISO format)

BOS, Isabelle et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. In: Alzheimer’s Research and Therapy, 2018, vol. 10, n° 1, p. 64. doi: 10.1186/s13195-018-0396-5

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1758-9193
508views
0downloads

Technical informations

Creation

24/10/2018 11:17:00

First validation

24/10/2018 11:17:00

Update

15/03/2023 16:01:24

Status update

15/03/2023 16:01:22

Last indexation

31/10/2024 13:00:36
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated